Kim S, Shin J, Kim D, Kim M, Kim E, Moon H
Eur Radiol. 2015; 26(7):2317-26.
PMID: 26497503
DOI: 10.1007/s00330-015-4067-7.
Bokacheva L, Kaplan J, Giri D, Patil S, Gnanasigamani M, Nyman C
J Magn Reson Imaging. 2013; 40(4):813-23.
PMID: 24273096
PMC: 4786009.
DOI: 10.1002/jmri.24462.
Nagalla S, Chou J, Willingham M, Ruiz J, Vaughn J, Dubey P
Genome Biol. 2013; 14(4):R34.
PMID: 23618380
PMC: 3798758.
DOI: 10.1186/gb-2013-14-4-r34.
Xiang L, Liu Z, Huan Q, Su P, Du G, Wang Y
Diagn Pathol. 2012; 7:32.
PMID: 22452996
PMC: 3337233.
DOI: 10.1186/1746-1596-7-32.
Xiang L, Su P, Xia S, Liu Z, Wang Y, Gao P
Diagn Pathol. 2011; 6:90.
PMID: 21943250
PMC: 3191358.
DOI: 10.1186/1746-1596-6-90.
The expression of ERCC1, RRM1, and BRCA1 in breast cancer according to the immunohistochemical phenotypes.
Kim D, Jung W, Koo J
J Korean Med Sci. 2011; 26(3):352-9.
PMID: 21394302
PMC: 3051081.
DOI: 10.3346/jkms.2011.26.3.352.
Clinicopathlogic and immunohistochemical characteristics of triple negative invasive lobular carcinoma.
Koo J, Jung W
Yonsei Med J. 2010; 52(1):89-97.
PMID: 21155040
PMC: 3017713.
DOI: 10.3349/ymj.2011.52.1.89.
Impact of grade, hormone receptor, and HER-2 status in women with breast cancer on response to specific chemotherapeutic agents by in vitro adenosine triphosphate-based chemotherapy response assay.
Koo J, Jung W, Shin E, Lee H, Jeong J, Kim K
J Korean Med Sci. 2009; 24(6):1150-7.
PMID: 19949674
PMC: 2775866.
DOI: 10.3346/jkms.2009.24.6.1150.
A proposal for a new histological classification scheme for predicting short-term tumor recurrence and death in patients with invasive ductal carcinoma of the breast.
Hasebe T, Imoto S, Sasaki S, Mukai K
Jpn J Cancer Res. 1999; 89(12):1358-73.
PMID: 10081498
PMC: 5921741.
DOI: 10.1111/j.1349-7006.1998.tb00534.x.
Histopathology of breast cancer in relation to age.
Fisher C, Egan M, Smith P, Wicks K, Millis R, Fentiman I
Br J Cancer. 1997; 75(4):593-6.
PMID: 9052416
PMC: 2063298.
DOI: 10.1038/bjc.1997.103.
The possible role of stromal cell stimulation in worsening the prognosis of a subset of patients with breast cancer.
Stewart T, Tsai S
Clin Exp Metastasis. 1993; 11(4):295-305.
PMID: 8319378
DOI: 10.1007/BF00058049.
Mononuclear stromal reactions in mammary carcinoma, with special reference to medullary carcinomas with a lymphoid infiltrate. Analysis of 108 cases.
BASSLER R, Dittmann A, Dittrich M
Virchows Arch A Pathol Anat Histol. 1981; 393(1):75-91.
PMID: 7347444
DOI: 10.1007/BF00430872.
The cancer research campaign (King's/Cambridge trial for early breast cancer: clinico-pathological aspects.
Elston C, GRESHAM G, Rao G, ZEBRO T, Haybittle J, Houghton J
Br J Cancer. 1982; 45(5):655-69.
PMID: 7044401
PMC: 2011009.
DOI: 10.1038/bjc.1982.106.
Inferring the natural time history of breast cancer: implications for tumor growth rate and early detection.
FELDSTEIN M, Zelen M
Breast Cancer Res Treat. 1984; 4(1):3-10.
PMID: 6697009
DOI: 10.1007/BF01806982.
Mammary skin oedema: a new prognostic indicator for breast cancer.
Shukla H, Gravelle I, Hughes L, Newcombe R, Williams S
Br Med J (Clin Res Ed). 1984; 288(6427):1338-41.
PMID: 6424848
PMC: 1440979.
DOI: 10.1136/bmj.288.6427.1338.
Characterisation of breast cancer infiltrates using monoclonal antibodies to human leucocyte antigens.
Rowe D, Beverley P
Br J Cancer. 1984; 49(2):149-59.
PMID: 6365132
PMC: 1976689.
DOI: 10.1038/bjc.1984.27.
Lymphocytes infiltrating human breast cancers lack K-cell activity and show low levels of NK-cell activity.
Eremin O, Coombs R, Ashby J
Br J Cancer. 1981; 44(2):166-76.
PMID: 6268135
PMC: 2010737.
DOI: 10.1038/bjc.1981.167.
The relative significance of prognostic factors in breast carcinoma.
Alderson M, Hamlin I, Staunton M
Br J Cancer. 1971; 25(4):646-56.
PMID: 5144532
PMC: 2008856.
DOI: 10.1038/bjc.1971.80.
Lymphoreticular infiltration in human tumours: prognostic and biological implications: a review.
Underwood J
Br J Cancer. 1974; 30(6):538-48.
PMID: 4614858
PMC: 2009334.
DOI: 10.1038/bjc.1974.233.
Fibrosis as in indication of time in infiltrating breast cancer and its importance in prognosis.
Anastassiades O, PRYCE D
Br J Cancer. 1974; 29(3):232-9.
PMID: 4364382
PMC: 2009096.
DOI: 10.1038/bjc.1974.62.
